Form 4: KORU Medical Systems CEO Linda Tharby Reports Stock Transactions
SEC Form 4 Filing
Linda Tharby, CEO of KORU Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding, affecting her beneficial ownership.
Summary
- On March 17, 2025, Linda Tharby, CEO of KORU Medical Systems, vested 15,968 shares of common stock from restricted stock units.
- Shares were withheld to cover tax obligations: 8,848 shares on March 17, 2025, at $2.8873 per share and 29,813 shares on March 19, 2025, at $2.83 per share.
- Following these transactions, Tharby's directly held beneficial ownership stands at 1,046,750 shares of common stock.
- The vested restricted stock units were granted under the Issuer's 2024 Omnibus Equity Incentive Plan and vest in equal increments on March 15, 2025, and each first, second and third anniversaries thereof.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The vesting of restricted stock units indicates that performance milestones or time-based vesting requirements have been met.
Future Outlook
The document does not contain explicit forward-looking statements, but it references vesting schedules for restricted stock awards based on market capitalization and net sales growth targets through 2025.
Industry Context
Form 4 filings are standard disclosures for company insiders and provide transparency regarding their transactions in the company's stock. This filing indicates routine vesting and tax-related transactions.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies, ensuring transparency in insider trading.
- Vesting schedules tied to market capitalization and net sales growth are common performance-based compensation mechanisms, aligning management's interests with shareholder value.
- Companies like Medtronic and Baxter International also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions, providing transparency into insider activity.
- The vesting of restricted stock units may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 12/31/22 | Fiscal year end for one of the net sales growth targets related to restricted stock awards. |
| 12/31/23 | Fiscal year end for one of the net sales growth targets related to restricted stock awards. |
| 12/31/24 | Fiscal year end for one of the net sales growth targets related to restricted stock awards. |
| 12/31/25 | Fiscal year end for one of the net sales growth targets related to restricted stock awards. |
| 03/15/27 | Date before which market capitalization targets must be met for vesting of restricted stock awards. |
| 03/17/2025 | Date of restricted stock unit vesting and tax withholding. |
| 03/19/2025 | Date of tax withholding. |
| 03/21/2025 | Date of Form 4 signature. |
Keywords
KORU Medical Systems, Linda Tharby, restricted stock units, beneficial ownership, Form 4, KRMD, vesting, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.